Glucagon-Like Peptide 1: all 44 studies that test it

Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.

• Supplementation of Gut-brain Axis (GLP-1)-Activating Carbohydrates for Increasing Satiety in Adolescents With ObesityNot yet recruitingNCT07823452Phase 2
• The Effects of LEUVATE on Glycemia, Insulinemia, Aminoacidemia, and Protein Synthesis in GLP-1 RA-treated AdultsNot yet recruitingNCT07595575Not applicable
• Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 InfusionRecruitingNCT07398300Not applicable
• Combination Therapy for Alcohol Use DisorderNot yet recruitingNCT07249554Phase 2
• Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity MeasuresEnrolling by invitationNCT07092605Early Phase 1
• Beta-cell Response to Incretin Hormones in Cystic FibrosisRecruitingNCT01851694Not applicable
• Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass SurgeryRecruitingNCT00992901Early Phase 1
• The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill PatientsTerminatedNCT00798590Phase 2Results posted
• The Effect of Surgically Induced Weight Loss on Endocrine Function, Cardiovascular Function and Body CompositionTerminatedNCT00686972Phase 2Results posted
• Effect of GLP-1 on Insulin Biosynthesis and Turnover RatesTerminatedNCT00609154Phase 1/2Results posted
• GLP1R Polymorphisms and Response to GLP1CompletedNCT00588380Not applicableResults posted
• GLP-1 Medicines and Mental Health ChangesCompletedNCT07368855Not applicable
• Glucagon-like Peptide-1 in Type 1 DiabetesWithdrawnNCT04355832Early Phase 1
• Acute Effects of GLP-1 on Renal HemodynamicsCompletedNCT04337268Not applicable
• Effect of GLP-1 on Microvascular Insulin Responses in Type 1 DiabetesWithdrawnNCT04133922Early Phase 1
• The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without SulphonylureaCompletedNCT03081676Not applicable
• GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in HumansCompletedNCT02731664Phase 1
• Effects of GLP-1 on Chronic Heart FailureStatus unknownNCT02650596Not applicable
• GLP-1 Effects on Insulin and Glucagon in PTDMCompletedNCT02591849Not applicable
• GLP-1 on Non-ST-Segment Elevation Myocardial InfarctionStatus unknownNCT02577848Not applicable
• Incretin Action in Physiology and DiabetesCompletedNCT02550548Phase 1
• Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon LiraglutidTerminatedNCT02417103Phase 3
• Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal MuscleCompletedNCT02370745Not applicable
• The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart FailureCompletedNCT02129179Phase 1
• GLP-1 Loading During Elective Percutaneous Coronary InterventionStatus unknownNCT02127996Phase 2
• Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes MellitusStatus unknownNCT01954147Phase 1/2
• GLP-1 and HypoglycemiaActive, not recruitingNCT01858896Early Phase 1
• Incretin Regulation of Insulin Secretion in Monogenic DiabetesCompletedNCT01795144Phase 1
• Effect of GLP-1 on Postprandial Lipid MetabolismStatus unknownNCT01760772Not applicable
• Hyperglycemia and the Extra-pancreatic Effect of IncretinsCompletedNCT01749163Not applicable
• The Microvascular Function of GLP-1 and Its AnaloguesCompletedNCT01677104Not applicable
• Intact Vagal Innervation and Glucagon-like Peptide-1 (GLP-1) EffectsStatus unknownNCT01176890Not applicable
• Effects of Intravenous Infusions of Gut Hormones on Appetite and Metabolism.CompletedNCT00940134Not applicable
• Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes MellitusCompletedNCT00923962Not applicable
• GLP 1 for Intraoperative Glycemic ControlCompletedNCT00882492Phase 1
• Characterization of Beta Cell FailureWithdrawnNCT00869102Not applicable
• Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic PatientsCompletedNCT00859079Phase 4
• Glucagon-like Peptide 1 (GLP-1) and Endothelial Dysfunction in Metabolic SyndromeCompletedNCT00856700Not applicable
• Effects of Oral GLP-1 on Glucose Homeostasis and Appetite Profile in Healthy Male SubjectsCompletedNCT00822003Phase 1/2
• Beta-Cell Function After Near-Normalisation of Blood GlucoseCompletedNCT00612950Not applicable
• Near Normalisation of BG Improves the Potentiating Effect of GLP-1CompletedNCT00612625Not applicable
• The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During HypoglycemiaCompletedNCT00418288Not applicable
• Effect of 48 Hours of Treatment With the Natural Peptide-Hormone GLP-1 in Patients With Chronic Heart FailureCompletedNCT00264199Not applicable
• The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy MenCompletedNCT00256256Not applicable

← Glucagon-Like Peptide 1 overview